Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global ELISA Kits Market to Surpass USD 418.5 Billion by 2025

By LabMedica International staff writers
Posted on 09 Mar 2020
The global ELISA (Enzyme-Linked Immunosorbent Assay) Kits market is projected to grow at a CAGR of 3.8% to surpass USD 418.5 billion by the year 2025, driving a CAGR of 4% in the worldwide Research ELISA market which is expected to reach USD 143.7 billion.

These are the latest findings of Global Industry Analysts, Inc. More...
(San Jose, CA, USA), a publisher of off-the-shelf market research.

Within the developed world, the ELISA Kits market in the US is projected to maintain a growth of 3.1%. Within Europe, which remains an important element in the world economy, Germany will add over USD 5.2 billion to the region's ELISA Kits market over the next five to six years. Over USD 4.2 billion worth of projected demand for ELISA kits in the region is expected to come from the Rest of Europe markets.

The Japanese ELISA Kits market is expected to reach a size of USD 24.4 billion by 2025. As the world's second-largest economy and the new game changer in the global markets, China’s ELISA Kits market is projected to grow at 6.2% over the next couple of years and add approximately USD 40.1 billion in terms of addressable opportunity. Several macroeconomic factors and internal market forces will shape the growth and development of demand patterns of the ELISA Kits market in the emerging countries in Asia-Pacific, Latin America and the Middle East.

Related Links:
Global Industry Analysts, Inc.


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.